Press release

12 | 05 | 11

GATC Biotech and LifeCodexx develop a diagnostic test for early detection of preeclampsia

Project is funded with 500,000 Euros from the BMBF

Preeclampsia is a hypertensive disorder of the mother during pregnancy. It is among the leading causes of death of mother and unborn child and occurs in approximately two to five percent of all pregnancies in Germany. Early detection is critical and improves...

14 | 04 | 11

Successful pilot study for non-invasive prenatal diagnostic test to determine trisomy 21

Launch planned for end of 2011

At the moment, the only reliable way of diagnosing chromosomal irregularities during pregnancy is to use invasive prenatal methods. This causes miscarriage in about one per cent of these risky surgical procedures.

Scientists from the Center for Prenatal Diagnosis and...

25 | 02 | 11

GATC Biotech Ltd. once again becomes a preferred supplier to the Research Councils of the UK

Following the previously won tender of 2006, GATC Biotech Ltd. has again been selected as a preferred supplier of DNA sequencing by the Research Councils UK Shared Services Centre Ltd (RCUK SSC Ltd.) until the end of 2012.

The company...

27 | 01 | 11

Mayor Horst Frank: GATC is a Constance flagship company

The GATC Biotech management and employees welcomed local political and industrial leaders, the architect, and construction companies to celebrate the inauguration of the newly constructed GATC facilities in Constance.

For Mayor Horst Frank GATC Biotech is a model company for the area. He looks forward to many imitators,...